NCT00141505View on ClinicalTrials.gov

PK Effects of Bifeprunox & Valproate in Bipolar I

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Bipolar I Disorder
Interventions
DRUG

Bifeprunox

Trial Locations (1)

Unknown

Site 1, Atlanta

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00141505 - PK Effects of Bifeprunox & Valproate in Bipolar I | Biotech Hunter | Biotech Hunter